I. Missitzis

发表

Quantitative Fluorescence Cytometric Measurement of Estrogen and Progesterone Receptors: Correlation with the Hormone Binding Assay

M. Alexis, J. Yotis, A. Gritzapis, 2003, Breast Cancer Research and Treatment.

The expression of the CEACAM19 gene, a novel member of the CEA family, is associated with breast cancer progression.

A. Scorilas, K. Michaelidou, A. Ardavanis, 2013, International journal of oncology.

The expression of the CEACAM 19 gene , a novel member of the CEA family , is associated with breast cancer progression

A. Scorilas, K. Michaelidou, A. Ardavanis, 2022 .

Psychosocial Adjustment to Illness Scale: Factor structure, reliability, and validity assessment in a sample of Greek breast cancer patients

I. Missitzis, F. Anagnostopoulos, Philippa Kolokotroni, 2017, Women & health.

Tumor specific cytolysis by tumor infiltrating lymphocytes in breast cancer

M. Papamichail, C. Baxevanis, G. Stathopoulos, 1994, Cancer.

Increased Frequency of CD4+ Cells Expressing CD161 in Cancer Patients

M. Karamouzis, S. Perez, M. Papamichail, 2006, Clinical Cancer Research.

Matrix-producing Breast Carcinoma: A Rare Subtype of Metaplastic Breast Carcinoma

Nektarios Koufopoulos, I. Missitzis, S. Kokkali, 2019, Cureus.

Enhanced human lymphokine‐activated killer cell function after brief exposure to granulocyte‐macrophage–colony stimulating factor

N. Papadopoulos, G. Dedoussis, M. Papamichail, 1995, Cancer.

Identification of novel breast cancer‐associated transcripts by uniGene database mining and gene expression analysis in normal and malignant cells

G. Ball, I. Ellis, R. Rees, 2013, Genes, chromosomes & cancer.

Induction of anti-tumour lymphocytes in cancer patients after brief exposure to supernatants from cultures of anti-CD3-stimulated allogeneic lymphocytes.

G. Spanakos, M. Papamichail, C. Baxevanis, 1997, British Journal of Cancer.

Elevated prostaglandin E2 production by monocytes is responsible for the depressed levels of natural killer and lymphokine‐activated killer cell function in patients with breast cancer

A. Gritzapis, M. Papamichail, C. Baxevanis, 1993, Cancer.

Synergy between interleukin-2 and prothymosin α for the increased generation of cytotoxic T lymphocytes against autologous human carcinomas

A. Gritzapis, M. Papamichail, C. Baxevanis, 2000, Cancer Immunology, Immunotherapy.

BCL2L12: a promising molecular prognostic biomarker in breast cancer.

A. Scorilas, G. Zografos, Athina Kladi-Skandali, 2014, Clinical biochemistry.

Identification and characterization of a HER-2/neu epitope as a potential target for cancer immunotherapy

A. Mamalaki, S. Perez, A. Gritzapis, 2010, Cancer Immunology, Immunotherapy.

Identification of a Novel Immunogenic HLA-A*0201-Binding Epitope of HER-2/neu with Potent Antitumor Properties1

S. Perez, A. Gritzapis, M. Papamichail, 2008, The Journal of Immunology.

with Potent Antitumor Properties HLA-A*0201-Binding Epitope of HER-2/neu Identification of a Novel Immunogenic

S. Perez, M. Papamichail, C. Baxevanis, 2013 .

Potent Antitumor Properties neu HLA-A * 0201-Binding Epitope of HER-2 / Identification of a Novel Immunogenic

S. Perez, A. Gritzapis, M. Papamichail, 2008 .

Natural CD8+ T-cell responses against MHC class I epitopes of the HER-2/neu oncoprotein in patients with epithelial tumors

S. Perez, M. Papamichail, C. Baxevanis, 2003, Cancer Immunology, Immunotherapy.

Cytotoxic T-cell precursor frequencies to HER-2 (369 – 377) in patients with HER-2/neu-positive epithelial tumours

S. Perez, C. Baxevanis, H. Echner, 2003, British Journal of Cancer.

Multidisciplinary therapy of locally far-advanced or inflammatory breast cancer with fixed perioperative sequence of epirubicin, vinorelbine, and Fluorouracil chemotherapy, surgery, and radiotherapy: long-term results.

A. Scorilas, N. Arnogiannaki, A. Ardavanis, 2006, The oncologist.

Human kallikrein-related peptidase 12 (KLK12) splice variants expression in breast cancer and their clinical impact

A. Scorilas, M. Talieri, A. Ardavanis, 2012, Tumor Biology.

Neoadjuvant sequential epirubicin and docetaxel followed by surgery-radiotherapy and post-operative docetaxel or gemcitabine/vinorelbine combination based on primary response: a multimodality approach for locally advanced breast cancer

P. Kountourakis, N. Arnogiannaki, A. Ardavanis, 2011, Journal of Cancer Research and Clinical Oncology.

Fibroadenoma Arising in Axillary Ectopic Breast Tissue. A Diagnostic Challenge

C. Kittas, Nektarios Koufopoulos, I. Missitzis, 2023, Cureus.

A. Scorilas, J. Griniatsos, K. Mavridis, 2018, Clinical and Experimental Medicine.

Integrating Microstructured Electrospun Scaffolds in an Open Microfluidic System for in Vitro Studies of Human Patient-Derived Primary Cells.

V. Guarino, L. Ambrosio, G. Bertalot, 2020, ACS biomaterials science & engineering.

Cathepsin D may help in discriminating node-negative breast cancer patients at risk for local-regional recurrence.

A. Scorilas, A. Ardavanis, A. Loukeri, 1998, Anticancer research.